Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 20,013 | 10,343 | 10,051 | 116,306 | 2,700 |
| Gross Profit | 20,013 | 10,343 | 10,051 | 116,306 | 2,700 |
| Operating Expenses | 47,868 | 49,859 | 43,271 | 44,526 | 44,245 |
| Operating Income | -27,855 | -39,516 | -33,220 | 71,780 | -41,545 |
| Interest Expense | 2,141 | 2,028 | 1,975 | 1,775 | 1,543 |
| Other Income | 2,540 | 2,697 | 2,169 | 656 | 52 |
| Pre-tax Income | -27,456 | -38,847 | -33,026 | 70,661 | -43,036 |
| Income Tax | N/A | N/A | 292 | 252 | N/A |
| Net Income Continuous | -27,456 | -38,847 | -33,318 | 70,409 | -43,036 |
| Net Income | $-27,456 | $-38,847 | $-33,318 | $70,409 | $-43,036 |
| EPS Basic Total Ops | -0.32 | -0.45 | -0.19 | 0.92 | -0.69 |
| EPS Basic Continuous Ops | -0.32 | -0.45 | -0.20 | 0.92 | -0.69 |
| EPS Diluted Total Ops | -0.32 | -0.45 | -0.19 | 0.92 | -0.69 |
| EPS Diluted Continuous Ops | -0.32 | -0.45 | -0.19 | 0.92 | -0.69 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.45 | -0.39 | N/A | N/A |
| EBITDA(a) | $-28,361 | $-40,158 | $-32,959 | $72,985 | $-40,150 |